Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of adiposity and metabolism in Lmna-deficient mice.

Biochemical and biophysical research communications - 1 Mar 2002

Cutler Dedra A, Sullivan Teresa, Marcus-Samuels Bernice, Stewart Colin L, Reitman Marc L

Abstract excerpt

Dunnigan's Familial Partial Lipodystrophy (FPLD) is an autosomal dominant disease characterized by regional fat loss and insulin resistance. FPLD is caused by mutations in the LMNA gene, which encodes intermediate filaments of the nuclear lamina. Different LMNA mutations cause Emery-Dreifuss muscular dystrophy and/or a dilated cardiomyopathy. It is not known how LMNA mutations cause any of the disease phenotypes....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Triglycerides
Share to Adipose Tissue
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Eating

Share to Lamins

Share to Lipodystrophy

Share to Muscular Dystrophies

Share to Tissue Distribution

Source

Identifiers

PMID: 11855819
DOI: 10.1006/bbrc.2002.6466

Genes

LMNA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of adiposity and metabolism in Lmna-deficient mice.PMID 11855819Read ↗

The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.Semantic proximity Read ↗

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.Semantic proximity Read ↗

A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy.Semantic proximity Read ↗

New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.Semantic proximity Read ↗

LMNA Mutations G232E and R482L Cause Dysregulation of Skeletal Muscle Differentiation, Bioenergetics, and Metabolic Gene Expression Profile.Semantic proximity Read ↗

Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.Semantic proximity Read ↗

Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome.Semantic proximity Read ↗

Post-natal myogenic and adipogenic developmental: defects and metabolic impairment upon loss of A-type lamins.Semantic proximity Read ↗

Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.Semantic proximity Read ↗

Abnormal in LMNA Triggers a Shift in Intracellular Metabolic Homeostasis Via AMPK ActivationSemantic proximity Read ↗

Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.Semantic proximity Read ↗

Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.